Literature DB >> 25097764

Recognition, Investigation and Management of Acute Transfusion Reactions: Consensus guidelines for Oman.

Arwa Z Al-Riyami1, Sabria Al-Hashmi2, Zainab Al-Arimi3, Louis D Wadsworth4, Abdulhakim Al-Rawas5, Murtadha Al-Khabori1, Shahina Daar6.   

Abstract

The recognition and management of transfusion reactions (TRs) are critical to ensure patient safety during and after a blood transfusion. Transfusion reactions are classified into acute transfusion reactions (ATRs) or delayed transfusion reactions, and each category includes different subtypes. Different ATRs share common signs and symptoms which can make categorisation difficult at the beginning of the reaction. Moreover, TRs are often under-recognised and under-reported. To ensure uniform practice and safety, it is necessary to implement a national haemovigilance system and a set of national guidelines establishing policies for blood transfusion and for the detection and management of TRs. In Oman, there are currently no local TR guidelines to guide physicians and hospital blood banks. This paper summarises the available literature and provides consensus guidelines to be used in the recognition, management and reporting of ATRs.

Entities:  

Keywords:  Blood Safety; Blood Transfusion; Health Planning Guidelines; Oman; Transfusion Reactions

Year:  2014        PMID: 25097764      PMCID: PMC4117654     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  23 in total

Review 1.  Bacterial contamination of platelet concentrates: incidence, significance, and prevention.

Authors:  M A Blajchman; M Goldman
Journal:  Semin Hematol       Date:  2001-10       Impact factor: 3.851

Review 2.  Transfusion-related acute lung injury.

Authors:  Christopher C Silliman; Nathan J D McLaughlin
Journal:  Blood Rev       Date:  2005-12-19       Impact factor: 8.250

3.  A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets.

Authors:  N M Heddle; L Klama; R Meyer; I Walker; L Boshkov; R Roberts; S Chambers; L Podlosky; P O'Hoski; M Levine
Journal:  Transfusion       Date:  1999-03       Impact factor: 3.157

4.  Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodgers specificity.

Authors:  P Lambin; P Y Le Pennec; G Hauptmann; O Desaint; B Habibi; C Salmon
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

5.  Blood transfusion reactions in children: associated factors.

Authors:  Anna K K V Pedrosa; Francisco J M Pinto; Luiza D B Lins; Grace M Deus
Journal:  J Pediatr (Rio J)       Date:  2013-06-20       Impact factor: 2.197

Review 6.  The two-event model of transfusion-related acute lung injury.

Authors:  Christopher C Silliman
Journal:  Crit Care Med       Date:  2006-05       Impact factor: 7.598

7.  Acute transfusion reactions in the pediatric intensive care unit.

Authors:  France Gauvin; Jacques Lacroix; Pierre Robillard; Hélène Lapointe; Heather Hume
Journal:  Transfusion       Date:  2006-11       Impact factor: 3.157

8.  The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill.

Authors:  Guangxi Li; Craig E Daniels; Marija Kojicic; Tami Krpata; Greg A Wilson; Jeffrey L Winters; S Breanndan Moore; Ognjen Gajic
Journal:  Transfusion       Date:  2008-10-14       Impact factor: 3.157

Review 9.  The pathogenesis of transfusion-related acute lung injury (TRALI).

Authors:  Jürgen Bux; Ulrich J H Sachs
Journal:  Br J Haematol       Date:  2007-03       Impact factor: 6.998

10.  The approach taken to reducing the risk of transfusion related acute lung injury in Canada.

Authors:  G H Growe; T R Petraszko; Mark Bigham
Journal:  Asian J Transfus Sci       Date:  2008-07
View more
  1 in total

1.  Role of Pharmacovigilance in India: An overview.

Authors:  Sanvidhan G Suke; Prabhat Kosta; Harsh Negi
Journal:  Online J Public Health Inform       Date:  2015-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.